Besides the involvement in the antimycobacterial response, these compounds are also related to the extent of pulmonary disease [20, 21], for which their increased presence during advanced disease may be more compatible with an inflammatory role, as is the case of increased IL-1β transcripts. Here, IL1B is linked to lung disorder.